Skip to main content

Read the latest news about TRIBEKA, an initiative driven whose mission is to generate an open access neuroimaging platform that allows to offer widely characterized information to advance the design of new treatments for Alzheimer's disesae and other neurodegenerative diseases.

19 Feb | 2019

Alfa and TRIBEKA join the Global Alzheimer’s Association Interactive Network

Data of the Study Alfa is now available, upon request, on the integrated online research platform launched by the Alzheimer’s Association.

20 Jul | 2017

José Luis Molinuevo presents TRIBEKA, a new consortium to investigate the prevention of Alzheimer's disease

El consorcio está formado por investigadores de Barcelona, Edimburgo y Estocolomo, y cuenta con un presupuesto de 2,1 millones de euros.